SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Biolase, Inc – ‘10-K’ for 12/31/13 – ‘EXCEL’

On:  Monday, 3/17/14, at 4:22pm ET   ·   For:  12/31/13   ·   Accession #:  1564590-14-856   ·   File #:  0-19627

Previous ‘10-K’:  ‘10-K’ on 3/15/13 for 12/31/12   ·   Next:  ‘10-K/A’ on 4/30/14 for 12/31/13   ·   Latest:  ‘10-K’ on 3/21/24 for 12/31/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/17/14  Biolase, Inc                      10-K       12/31/13   76:14M                                    ActiveDisclosure/FA

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.28M 
 2: EX-4        Ex-4.4                                              HTML     29K 
 3: EX-10       Ex-10.42                                            HTML     61K 
 4: EX-21       Ex-21.1                                             HTML     21K 
 5: EX-23       Ex-23.1                                             HTML     23K 
 6: EX-31       Ex-31.1                                             HTML     29K 
 7: EX-31       Ex-31.2                                             HTML     29K 
 8: EX-32       Ex-32.1                                             HTML     25K 
 9: EX-32       Ex-32.2                                             HTML     25K 
53: R1          Document and Entity Information                     HTML     53K 
43: R2          Consolidated Balance Sheets                         HTML    144K 
51: R3          Consolidated Balance Sheets (Parenthetical)         HTML     51K 
55: R4          Consolidated Statements Of Operations And           HTML    107K 
                Comprehensive Loss                                               
71: R5          Consolidated Statements Of Shareholders' Equity     HTML    101K 
                (Deficit)                                                        
45: R6          Consolidated Statements Of Cash Flows               HTML    176K 
50: R7          Basis of Presentation                               HTML     55K 
39: R8          Summary of Significant Accounting Policies          HTML    152K 
30: R9          Supplementary Balance Sheet Information             HTML    122K 
72: R10         Intangible Assets and Goodwill                      HTML     92K 
57: R11         Lines of Credit and Other Borrowings                HTML     44K 
56: R12         Income Taxes                                        HTML    190K 
62: R13         Commitments and Contingencies                       HTML     56K 
63: R14         Stockholders' Equity                                HTML    274K 
61: R15         Segment Information                                 HTML     49K 
64: R16         Concentrations                                      HTML     26K 
52: R17         Subsequent Events                                   HTML     38K 
54: R18         Schedule II-Consolidated Valuation and Qualifying   HTML     88K 
                Accounts and Reserves                                            
60: R19         Accounting Policies (Policies)                      HTML    306K 
76: R20         Summary of Significant Accounting Policies          HTML    109K 
                (Tables)                                                         
67: R21         Supplementary Balance Sheet Information (Tables)    HTML    129K 
47: R22         Intangible Assets and Goodwill (Tables)             HTML     83K 
58: R23         Income Taxes (Tables)                               HTML    183K 
49: R24         Commitments and Contingencies (Tables)              HTML     31K 
24: R25         Stockholders' Equity (Tables)                       HTML    229K 
68: R26         Segment Information (Tables)                        HTML     41K 
73: R27         Basis of Presentation - Additional Information      HTML     52K 
                (Detail)                                                         
34: R28         Estimated Useful Lives of Property, Plant and       HTML     28K 
                Equipment (Detail)                                               
33: R29         Changes in Initial Product Warranty Accrual and     HTML     41K 
                Expenses Under Initial and Extended Warranties                   
                (Detail)                                                         
37: R30         Classification of Compensation Expense Associated   HTML     32K 
                with Share-Based Payments (Detail)                               
38: R31         Assumptions Used in Estimating Fair Value of Stock  HTML     35K 
                Options Granted (Detail)                                         
40: R32         Summary of Significant Accounting Policies -        HTML     57K 
                Additional Information (Detail)                                  
22: R33         Components of Accounts Receivable, Net of           HTML     31K 
                Allowance (Detail)                                               
65: R34         Components of Inventory (Detail)                    HTML     34K 
46: R35         Summary of Property, Plant, and Equipment (Detail)  HTML     45K 
48: R36         Components of Accrued Liabilities (Detail)          HTML     51K 
27: R37         Summary of Deferred Revenue (Detail)                HTML     40K 
75: R38         Supplementary Balance Sheet Information -           HTML     48K 
                Additional Information (Detail)                                  
16: R39         Intangible Assets and Related Accumulated           HTML     56K 
                Amortization (Detail)                                            
41: R40         Intangible Assets and Goodwill - Additional         HTML     44K 
                Information (Detail)                                             
70: R41         Lines of Credit and Other Borrowings - Additional   HTML    137K 
                Information (Detail)                                             
26: R42         Summary of Income Tax Current and Deferred          HTML     69K 
                Provision (Benefit) (Detail)                                     
32: R43         Federal Income Tax Provision Compared With          HTML     63K 
                Statutory Rates (Detail)                                         
36: R44         Summary of Net Deferred Tax Assets and Net          HTML     87K 
                Deferred Tax Liabilities (Detail)                                
44: R45         Summary of Unrecognized Tax Benefits (Detail)       HTML     31K 
21: R46         Income Taxes - Additional Information (Detail)      HTML     58K 
29: R47         Commitments and Contingencies - Additional          HTML     41K 
                Information (Detail)                                             
18: R48         Future Minimum Rental Commitments Under Operating   HTML     45K 
                Lease Agreements (Detail)                                        
69: R49         Summary of Option Activity (Detail)                 HTML     81K 
25: R50         Options Outstanding and Exercisable (Detail)        HTML     70K 
66: R51         Cash Proceeds Along with Fair Value Disclosures     HTML     41K 
                Related to Grants Exercises and Vesting Options                  
                (Detail)                                                         
28: R52         Stockholders' Equity - Additional Information       HTML    251K 
                (Detail)                                                         
42: R53         Summary of Net Revenue by Geographic Location       HTML     27K 
                (Detail)                                                         
17: R54         Segment Information - Additional Information        HTML     32K 
                (Detail)                                                         
20: R55         Concentrations - Additional Information (Detail)    HTML     36K 
35: R56         Subsequent Events - Additional Information          HTML     67K 
                (Detail)                                                         
23: R57         Consolidated Valuation and Qualifying Accounts and  HTML     36K 
                Reserves (Detail)                                                
74: XML         IDEA XML File -- Filing Summary                      XML    111K 
19: EXCEL       IDEA Workbook of Financial Reports                  XLSX    190K 
31: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS   2.05M 
10: EX-101.INS  XBRL Instance -- biol-20131231                       XML   2.69M 
12: EX-101.CAL  XBRL Calculations -- biol-20131231_cal               XML    200K 
13: EX-101.DEF  XBRL Definitions -- biol-20131231_def                XML   1.08M 
14: EX-101.LAB  XBRL Labels -- biol-20131231_lab                     XML   1.53M 
15: EX-101.PRE  XBRL Presentations -- biol-20131231_pre              XML   1.21M 
11: EX-101.SCH  XBRL Schema -- biol-20131231                         XSD    220K 
59: ZIP         XBRL Zipped Folder -- 0001564590-14-000856-xbrl      Zip    215K 


‘EXCEL’   —   IDEA Workbook of Financial Reports


This is an IDEA Workbook.

        Download this Microsoft® Excel® .xlsx workbook

Top
Filing Submission 0001564590-14-000856   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Apr. 18, 3:35:35.1pm ET